Vaccine Development in India to be the Focus of Fireside Chat at BIO India International Conference
Washington, D.C. and Mumbai, India (August 14, 2012)–India is the world’s largest manufacturer of vaccines. Recognizing India as a model for the global vaccine market, the Biotechnology Industry Organization (BIO) is pleased to announce programming to highlight this achievement; a Fireside Chat: Vaccine Development in India will be held at the 3rd Annual BIO India International Conference, September 12-13 at the Grand Hyatt in Mumbai, India. BIO has partnered with the Association of Biotechnology Led Enterprises (ABLE), which represents Indian and Asian biotechnology and pharmaceutical companies, as well as leading investment banks and Venture Capital firms.
“BIO India will highlight the growth of India vaccine makers and their ability to make high-quality vaccines available at affordable prices, and present opportunities for Western companies seeking to do business within India’s borders,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.
Dr. Cyrus Poonawalla, Founder, Chairman, and Managing Director, Serum Institute of India Ltd. will discuss Vaccine Development in India during a Fireside Chat on Wednesday, September 12th, 5:00 – 6:00 p.m. Dr. Poonawalla estimates that one out of every two children immunized worldwide receives a vaccine produced by Serum Institute. Dr. Poonawalla has been called one of the most influential people in vaccines research and development.
Naazneen Karmali, India Editor, Forbes Asia, Mumbai Bureau Manager, Forbes will lead the discussion with Dr. Poonawalla.
Other sessions at BIO India include:
- Commercializing Stem Cell Therapies and Regenerative Medicine
This session will discuss India’s progress in stem cells and gene therapies, and the increasing use of these technologies to treat a host of diseases. What types of collaborations and funding are fueling the space in India? Companies at the forefront of the field will share their business strategies and discuss the commercial and regulatory issues involved with developing these specific treatments at the national and international level.
Thursday, September 13th, 10:00 – 11:00 a.m.
Panelists to date: B.N. Manohar, CEO, Stempeutics Research Pvt. Ltd. and Dr. Chandra Viswanathan, Head of Regenerative Medicine, Reliance Life Sciences
- Keynote and Plenary Luncheon: Strategies for Success: India’s Global Role in Innovation
It’s no secret that India’s healthcare market is vastly different from Western markets; however, India is quickly establishing itself as a global leader in the life sciences. What strategies have multinational biopharma companies employed to bolster innovation in this emerging market? Which policies help to foster this continued innovation and how can both Western & local companies leverage these to ensure success? What role do public-private partnerships play in facilitating funding for innovation? This panel will feature a candid discussion of India’s global role in biotech innovation and the mechanisms engaged to ensure success.
Thursday, September 13, 12:30 – 2:30 p.m.
Moderator: Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics Inc.
Panelists to date: Phil Kearney, PhD, MBA, Director, External Scientific Affairs, Worldwide Licensing, Merck
Confirmed keynote speakers for BIO India include: Sam Pitroda, Advisor to the Prime Minister of India on Public Information Infrastructure & Innovations and H. Thomas Watkins, Former CEO, Human Genome Sciences, A GlaxoSmithKline Company.
In addition to high-level keynote speakers and educational India-focused panels, the event offers networking opportunities, company presentations, and the BIO One-on-One Partnering™ system. BIO’s partnering system provides an interactive environment to intelligently search, contact and schedule private meetings with potential partners and investors. Learn more about the event here.
Through this conference and ongoing advocacy efforts, BIO aims to help the industry flourish within India's borders and help patients and citizens benefit from the promise of biotech. BIO brings to India more than ten years experience and expertise in biotechnology and pharmaceutical partnering. BIO is renowned for its successful partnering meetings held around the globe, including the industry’s largest partnering event – the BIO Business Forum at the BIO International Convention.
ABLE – Association of Biotechnology Led Enterprises is a national forum that represents the Indian Biotechnology Sector. The primary objective of ABLE is to accelerate the pace of growth of the Biotechnology Industry in India, through partnering with the Government of India in their Biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaborations and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector. ABLE thus catalyses a symbiotic interface between the industry, the government, academic and research institutes and domestic and international investors.